Connections +
News

IBM, MIT to pursue joint research in AI


September 8, 2017  


Print this page

IBM Corp. plans to make a 10-year, US$240 million investment to create the MIT–IBM Watson AI Lab in partnership with the Massachusetts Institute of Technology. The lab will carry out fundamental artificial intelligence (AI) research and seek to propel scientific breakthroughs that unlock the potential of AI.

The collaboration aims to advance AI hardware, software and algorithms related to deep learning and other areas, increase AI’s impact on industries, such as health care and cybersecurity, and explore the economic and ethical implications of AI on society. IBM’s US$240 million investment in the lab will support research by IBM and MIT scientists.

Plans are in the works to issue a call for proposals to MIT researchers and IBM scientists to submit their ideas for joint research to push the boundaries in AI science and technology in several areas, including:

*AI algorithms: Developing advanced algorithms to expand capabilities in machine learning and reasoning. Researchers will create AI systems that move beyond specialized tasks to tackle more complex problems, and benefit from robust, continuous learning. Researchers will invent new algorithms that can not only leverage big data when available, but also learn from limited data to augment human intelligence.

*Physics of AI: Investigating new AI hardware materials, devices, and architectures that will support future analog computational approaches to AI model training and deployment, as well as the intersection of quantum computing and machine learning. The latter involves using AI to help characterize and improve quantum devices, and also researching the use of quantum computing to optimize and speed up machine-learning algorithms and other AI applications.

*Application of AI to industries: The collaboration will explore the use of AI in areas such as the security and privacy of medical data, personalization of healthcare, image analysis, and the optimum treatment paths for specific patients.
“The field of artificial intelligence has experienced incredible growth and progress over the past decade,” said Dr. John Kelly III, IBM senior vice president of cognitive solutions and research. “Yet today’s AI systems, as remarkable as they are, will require new innovations to tackle increasingly difficult real-world problems to improve our work and lives.”